Unparalleled opportunities now exist to detect, diagnose, prevent and treat cancer due to the sequencing of the human genome, a greater understanding of cancer biology, progress in systems biology, and advances in computer science and other technologies. Capitalizing on these opportunities often depends on the participation of researchers in various specialties across the spectrum of cancer science and that also include chemistry, physics, engineering, computational science, and nanotechnology. The integration of such specialties into cancer research forms the bases of interdisciplinary scientific teams.
This award has been established by the American Association for Cancer Research and Eli Lilly and Company to acknowledge and catalyze the growing importance of interdisciplinary teams to the understanding of cancer and/or the translation of research discoveries into clinical cancer applications. Proactive interaction between academic and industry researchers is particularly crucial to continue progress and accelerate drug development.
In addition, through the presentation of this award, the AACR and Eli Lilly seek to effect change within the traditional cancer research culture by recognizing those institutions that value and foster interdisciplinary team science. These institutions will have demonstrated their support of a team science environment by creating mechanisms to enhance the required infrastructure, such as through pilot funding, technology transfer offices, shared resources, etc., and by presenting awards, honors, appointments, and promotions to those who participate in interdisciplinary teams.
The AACR Team Science Award will recognize an outstanding interdisciplinary research team for its innovative and meritorious science that has advanced or likely will advance our fundamental knowledge of cancer or a team that has applied existing knowledge to advance the detection, diagnosis, prevention or treatment of cancer.
The team selected to receive the AACR Team Science Award will collectively be awarded an honorarium of $50,000 and be recognized during the AACR Annual Meeting 2020 in San Diego, California, USA. The represented institutions will be cited at the AACR Annual Meeting for their leadership role in fostering team science in cancer research.